Medical Blog About Treatment Abroad

Alzheimer's disease (AD) is a major public health problem. According to the Alzheimer's Association, about 6.2 million people are living with the disease in the USA alone, and that number is projected to rise to nearly 14 million by 2050. Classic treatment eliminates symptoms and does not affect the underlying cause of the...

Breast cancer is the most common malignant disease among women in Europe. It is a heterogeneous disease, the pathogenesis of which remains unclear in most cases. Significant progress has been made in early diagnosis and treatment of breast cancer, which has led to improved survival rates. Different molecular subtypes of breast...

Renal cell carcinoma (RCC) accounts for approximately 90% of all kidney cancers and remains one of the ten most common cancers worldwide. In 2022 alone, more than 435,000 new cases were diagnosed globally, with over 156,000 deaths attributed to the disease. The incidence has been steadily increasing, particularly in high-income...

The regional chemotherapy (RCT) approach is an oncological approach with a very low toxicity profile and high tumor response due to high cytotoxic drug concentrations in an isolated perfusion bed. In addition, the therapy can be focused on limited regions if necessary, using the same technique (e.g., upper abdominal perfusion...

Globally, lung cancer remains the leading cause of cancer mortality, with about 2 million new diagnoses and 1.8 million deaths annually. Neoplasms of the lungs are the second most common cancer diagnosis among men and women worldwide (after prostate and breast cancer, respectively). This novel approach gained widespread popularity...

In 2020 over 573,000 new bladder cancer (BC) cases and around 212,000 BC deaths were estimated to occur worldwide, representing approximately 3% of all new cancer cases and more than 2% of cancer deaths. BC ranks as the tenth most common cancer diagnosed and the 13th most common cause of cancer mortality worldwide.

In the whole world, the German health care system is recognized as one of the best and most advanced systems. This is because it consistently delivers impressive patient outcomes. Worldometers shows that the average life expectancy in Germany is around 81.7 years. This data allows placing the country among the global leaders in...

In recent years, doctors in developed countries have increasingly used immunotherapy treatment for leukemia. Healthcare professionals in Germany use innovative drugs that help cope with even refractory and relapsing forms of leukemia. Immunotherapy is mainly used for acute lymphocytic leukemia.